About Pieris Pharmaceuticals

Website
Website
Employees
Employees
51-200 employees View all
Industry
Industry
biotechnology
Location
Location
255 State Street, 9th Floor,Boston,Massachusetts,US
Description
Information
Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Pieris is listed on the NASDAQ and trades under the ticker symbol PIRS. Pieris is currently hiring in Boston and Freising, Germany. See here for our full list of job openings and information on applying: https://www.pieris.com/careers

Pieris Pharmaceuticals Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
biotechnology

Frequently Asked Questions about Pieris Pharmaceuticals

What is Pieris Pharmaceuticals email format?

The widely used Pieris Pharmaceuticals email format is {last} (e.g. [email protected]) with 75% adoption across the company.


What is Pieris Pharmaceuticals customer service number?

To contact Pieris Pharmaceuticals customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more